Related Experiment Videos
Pharmacogenetics/genomics and personalized medicine
1Department of Pharmacology, Comprehensive Cancer Center, College of Medicine and Public Health, The Ohio State University, Columbus, OH 43210-1239, USA. sadee-1@medctr.osu.edu
Human Molecular Genetics
|October 26, 2005
Summary
Pharmacogenomics, the study of how genes affect drug response, faces challenges in clinical use. Overcoming these hurdles promises incremental advances toward personalized healthcare.
Area of Science:
- Pharmacogenomics and Personalized Medicine
Background:
- Individual responses to drug therapy vary significantly, leading to treatment failure or adverse effects.
- Genetic variations in drug metabolizing enzymes, transporters, and receptors are known contributors to this variability.
- Pharmacogenomics aims to leverage genetic information for tailored drug therapy and novel target identification.
Purpose of the Study:
- To review the current obstacles hindering the clinical implementation of pharmacogenomics.
- To identify key areas requiring further research and development for pharmacogenomic advancements.
Main Methods:
- Literature review and synthesis of existing pharmacogenomic research.
- Analysis of challenges in understanding complex gene-drug interactions and disease genetics.
- Evaluation of the current state of knowledge regarding genetic variations and their impact.
Main Results:
- Significant hurdles include the intricate mechanisms of drug response, the genetic complexity of common diseases (e.g., cancer, diabetes), and incomplete understanding of genetic variation scope.
- Pharmacogenomics has made limited progress in clinical practice despite its potential.
Conclusions:
- Resolving the identified obstacles is crucial for realizing the full potential of pharmacogenomics.
- Overcoming these challenges will lead to significant, albeit gradual, therapeutic improvements and advance personalized healthcare.